Autoinjectors Market to Reach $3.02 Billion by 2030 as Self-Injection Therapies Gain Momentum

According to MarketsandMarkets™, The report “Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) – Global Forecast to 2030 “, is projected to expand to a value of USD 3.02 billion in 2030 from USD 1.40 billion in 2024, with a significant CAGR of 13.6%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724

Browse

• 527 Market Data Tables
• 75 Figures
• 382 Pages and in-depth TOC on “ Autoinjectors Market – Global Forecast to 2030”

Some of the prominent key players are:

• Becton, Dickinson and Company (BD) (US),
• Ypsomed Holding AG (Switzerland),
• SHL Medical (Switzerland),
• West Pharmaceutical Services, Inc. (US),
• Recipharm AB (Sweden) and many more……

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Autoinjectors Market.

Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

• Based on the therapy area, the autoinjectors market is divided into rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, obesity, and other therapy areas. In 2023, the rheumatoid arthritis segment dominated the autoinjectors market and obesity segment is anticipated to grow at highest CAGR during the forecast period.
• Based on the usage, the autoinjectors market is further categorized into reusable and disposable autoinjectors. In 2023, the disposable segment accounted for the fastest-growing share of the usage segment of autoinjectors market.
• On the basis of the route of administration, the autoinjectors market is further categorized into subcutaneous and intramuscular. The subcutaneous route of administration is the most commonly used method for the treatment of various chronic disease conditions diabetes, rheumatoid arthritis, and multiple sclerosis which require long-term treatment.
• Based on the region, the autoinjector devices and autoinjector finished formulations market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global autoinjector devices and autoinjector finished formulations market in 2023 and likely to dominate throughout the forecast period.

Technology advancements in the autoinjector devices, such as improved design, addition of connectivity features for data tracking, bluetooth connectivity, dosage reminders are some of the factors increasing adoption of autoinjectors subsequently driving market growth. The prevalence of severe allergies has led to a significant demand for product like EpiPen (epinephrine autoinjectors) are essential for emergency treatment in developed and developing countries. Additionally, rising prevalence of chronic diseases and increasing adoption of biologics is further likely to boost the demand for the autoinjectors market. Furthermore, favourable regulatory policies and reimbursement policies in North America and Europe are some of the factors increasing adoption of autoinjectors in the region subsequently giving momentum to market growth.

Related Reports:

Insulin Delivery Device Market– Global Forecast to 2030

Pen Needles Market– Global Forecast to 2030

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html